Compared to Estimates, Teva Pharmaceutical Industries (TEVA) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2025, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $4.18 billion, up 0.3% over the same period last year. EPS came in at$ 0.66, compared to $0.61 in the year-ago quarter.The reported revenue represents a surprise of -2.47% over the Zacks Consensus Estimate of$ 4.28 billion. With the consensus EPS estimate being $0.63, the EPS surprise was +4.76%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...